Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MLNT - FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise

MLNT - FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise

Melinta Therapeutics Inc - Ordinary Shares
  • The FDA approves Melinta Therapeutics' (NASDAQ:MLNT) BAXDELA (delafloxacin) for the treatment of adults patients with community-acquired bacterial pneumonia (CABP).
  • More news on: Melinta Therapeutics, Inc., Healthcare stocks news, Stocks on the move,
    • Read more ...
Stock Information
Company Name: Melinta Therapeutics Inc - Ordinary Shares
Stock Symbol: MLNT
Market: NASDAQ
Website: melinta.com
Menu
MLNT MLNT Quote MLNT Short MLNT News MLNT Articles MLNT Message Board
Get MLNT Alerts

News, Short Squeeze, Breakout and More Instantly...